The original plan was to build LTC from CO2 seperator $$. It didn't happen.
DR has done amazingly well to line up Empire and Frank and push LTC ahead without the $$, so I don't begrudge him the 10 years: it was never going to be a smooth and easy road.
That said, none other than DR himself has stressed the importance of FDA approval. The last 10K made it clear that LTC wasn't being pursued in Europe, in spite of the strong and repeated wishes often touted on this board. LTC will move ahead when FDA approval occurs, which I sincerely hope will be this Q as DR "expects".
IMO, the recent presentations in the Czech Republic and the upcoming event in Florida were meant to act as sales pitches post-FDA approval. Rolling out a technique that can't be used yet isn't as effective as introducing the medical community to fully endorsed and sanctioned technique. My sense is that DR and Frank felt that they had fully complied with what the FDA wanted to see, and that they're becoming impatient with this prolonged delay.
There's a LOT at stake here, let's not kid ourselves: the investment world is packed with great ideas. Few progress to commercial entities. Fewer still become "disruptive" technologies. I'm a believer that FDA approval will happen, (but it's easy to be a believer at a basis price of .041). I don't want to consider the alternative yet, but as time goes by, I can certainly appreciate why investors would be cautious. After all, my original purchase was predicated on the news of gas sales to Dupont! (lol)
